Sign in

CIK 0001490978

  • Large accelerated filer

Schrodinger, Inc.

Sign in to watch
Ticker
SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954284541
Phone
+1 503-299-1150
Business address
1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
  1. 4 Derivatives Options or other derivatives
  2. 4 Option exercise EVP, CTO & COO, Software acquired 5,574 shares (option exercise)
  3. 4 Open-market sale EVP & CFO sold 3,315 shares at $26.35 ($87,360)
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award SVP & Controller acquired 7,313 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Planned sale EVP, CLO & CPO sold 758 shares at $28.29 ($21,444)
  12. 4 Planned sale See Remarks sold 1,205 shares at $27.55 ($33,198)
  13. 4 Planned sale SVP & Controller sold 787 shares at $28.29 ($22,264)
  14. 4 Planned sale EVP, CTO & COO, Software sold 901 shares at $28.29 ($25,489)
  15. 4 Option exercise SVP & Controller acquired 4,545 shares (option exercise)
  16. 4 Grant or award Chief Medical Officer acquired 15,000 shares (grant or award)
  17. 4 Planned sale EVP & Chief Technology Officer sold 10,000 shares at $40.06 ($400,642)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale EVP, CLO & CPO sold 12,040 shares at $50.00 ($602,000)
  20. 4 Grant or award Director acquired 6,250 shares (grant or award)

Page 5 of 17 · 326 filings